Stamford, CT -- (SBWIRE) -- 01/14/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: GSE Holding Inc (NYSE:GSE), Conatus Pharmaceuticals Inc (NASDAQ:CNAT), The Bon-Ton Stores, Inc. (NASDAQ:BONT), Prosensa Holding NV (NASDAQ:RNA)
GSE Holding Inc (NYSE:GSE) opened the session at $1.11, trading in a range of $0.72- $1.12. The stock showed a negative performance of -44.10% in the last trading session from its previous close of $1.39 and closed at $0.777. The stock traded on a volume of 4.65 million shares and the average volume of the stock remained 150,199 shares. GSE Holding, Inc. (GSE) is a provider of engineered geosynthetic containment solutions. GSE’s products are used in a range of infrastructure end markets, such as mining, waste management, liquid containment (including water infrastructure, agriculture and aquaculture), coal ash containment and shale oil and gas. The Company operates in two segments: North America, which represents the United States, Canada and Mexico, and International, which represents the rest of its global operations.
Has GSE Found The Bottom and Ready To Move Up? Find Out Here
Conatus Pharmaceuticals Inc (NASDAQ:CNAT) traded 1.67 million shares in the last business day while the average volume of the stock remained 511,421 shares. The stock showed a negative movement of -17.33% to end at $11.78. The 52 week range of the stock remained $5.76 - $15.67. Conatus Pharmaceuticals Inc. is a biotechnology company focused on the development and commercialization of medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. The Company has designed a clinical program to demonstrate the therapeutic benefit of emricasan across the spectrum of fibrotic liver disease.
Has CNAT Found The Bottom And Ready To Gain Momentum? Find Out Here
The Bon-Ton Stores, Inc. (NASDAQ:BONT) reported 1.83 million shares were exchanged during the last trade, while the average volume is about 272,068 shares. The stock dropped -13.48% and finished the day at $13.41. The beta of the stock is recorded at 2.94. The Bon-Ton Stores, Inc. is a department store operators in the United States, offering an assortment of apparel and accessories for women, men and children. The Company’s merchandise offerings also include cosmetics, home furnishings and other goods. The Company operates in two segments: Stores and eCommerce (its Internet websites).
Why Should Investors Buy BONT After the Recent Fall? Just Go Here and Find Out
Prosensa Holding NV (NASDAQ:RNA) shares dropped -12.48 percent from its previous close of $5.61 to close at $4.91. Traded with volume of 1.61 million shares in the prior session and the average volume of the stock remained 310,809 shares. Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders.
Will RNA Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)